Filing Details
Neuraxis, INC (NASDAQ:NRXS) filed a Form 8-K with the Securities and Exchange Commission on July 10, 2026, disclosing a material event.
8k filedNASDAQ:NRXS
Neuraxis, INC (NRXS) Reports Material Event to SEC
Filing Details Neuraxis, INC (NASDAQ:NRXS) filed a Form 8-K with the Securities and Exchange Commission on July 10, 2026, disclosing a material event. Market Context Neuraxis,…
Market Context
Neuraxis, INC's stock currently trades at $7.14 with a market capitalization of $28.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Neuraxis, INC's stock.
All SEC filings for Neuraxis, INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NRXS Stock Page
Frequently Asked Questions
Where can I read NRXS's SEC filings?
Browse all filings on our NRXS SEC filings page.
What types of SEC filings does Neuraxis, INC file?
Public companies like Neuraxis, INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.